MA H3574 | 2023-2024 | 193rd General Court
Note: Legislation replaced by H4739
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on March 30 2023 - 25% progression
Action: 2024-07-01 - Accompanied a study order, see H4739
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 30 2023 - 25% progression
Action: 2024-07-01 - Accompanied a study order, see H4739
Text: Latest bill text (Introduced) [PDF]
Summary
Relative to the use of a certain prescription medication used in psychotherapy and the treatment of post-traumatic stress disorder. Elder Affairs.
Title
Concerning the use of a prescription medicine that contains 3,4-methylenedioxymethamphetamine (MDMA)
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2024-07-01 | House | Accompanied a study order, see H4739 |
| 2023-05-26 | Joint | Hearing scheduled for 06/06/2023 from 01:00 PM-05:00 PM in Gardner Auditorium |
| 2023-04-18 | Senate | Senate concurred |
| 2023-04-13 | House | Discharged to the Joint Committee on Public Health |
| 2023-03-30 | Senate | Senate concurred |
| 2023-03-30 | House | Referred to the Joint Committee on Elder Affairs |
Same As/Similar To
H4739 (Replaced by) 2024-07-01 - Discharged to the committee on House Rules
Massachusetts State Sources
| Type | Source |
|---|---|
| Summary | https://malegislature.gov/Bills/193/H3574 |
| Text | https://malegislature.gov/Bills/193/H3574.pdf |
